Global Hemodynamic MonitoringSystem Market: Drivers
Increasing prevalence ofcongenital heart disease is expected to propel growth of the global HemodynamicMonitoring System Market over the forecast period. For instance, accordingto the study, Prevalence, profile, and pattern of congenital heart disease inCentral India: A prospective, observational study (published in May 2018), theprevalence of congenital heart disease (CHD) was 10.13/1000 live births.
Hemodynamic monitoring systemsare used in hospitals, clinics, home care settings, ambulatory surgery centers,and independent catheterization laboratories. Some of these systems include,vital sign monitors, pulse oximeters, central venous catheters, non-invasiveblood pressure monitors, and pulmonary artery catheters. The global hemodynamicmonitoring system market is estimated to account for US$ 10,846.3 Mn in termsof value by the end of 2027.
Global Hemodynamic MonitoringSystem Market: Opportunities
The use of the deep-learningmethod to build certain kinds of prediction model is increasing in the medicalfield. Therefore, key players in the market can focus on integratingdeep-learning method to enhance stroke volume (SV) estimation by arterial bloodpressure.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1070
Global Hemodynamic MonitoringSystem Market: Restraints
However, use of hemodynamicmonitoring systems is associated with complications such as dysrhythmias,balloon rupture, knotting of the catheter, infection, pulmonary infarction,pulmonary artery rupture, and deep vein thrombosis, which is expected to hampergrowth of the market.
Key Takeaways:
The Pulse Oximeters segment inthe global hemodynamic monitoring system market was valued at US$ 718.0 Mn in2018 and is expected to reach US$ 1,078.6 Mn by 2027 at a CAGR of 13.4% duringthe forecast period. The growth of the segment is attributed to increasingpatient population suffering from chronic diseases. The Invasive HemodynamicMonitoring segment held dominant position in the global hemodynamic monitoringsystem market in 2018, accounting for 49.4% share in terms of volume, followedby Non-Invasive Hemodynamic Monitoring, and Minimally Invasive HemodynamicMonitoring, respectively. Technological advancement and increasing productapprovals is anticipated to propel the growth of the segment during the forecastperiod
Market Trends:
The preference for home caresettings compared to hospitals is increasing due to growing concerns over theaging population and relatively high costs incurred during hospitalization ofpeople suffering from chronic illness. Key players in the market are focused ondeveloping single monitoring platform. For instance, in July 2019, CaretakerMedical partnered with Mespere LifeSciences to integrate wireless CNIBP,Cerebral Oximetry, and other non-invasive hemodynamic measurements in a singlemonitoring platform.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/hemodynamic-monitoring-systems-market-1070
Global Hemodynamic MonitoringSystem Market: Competitive Landscape
Major players operating in theglobal hemodynamic monitoring system market include, Edwards LifesciencesCorporation, ICU Medical, Inc., PULSION Medical Systems SE, Koninklijke PhilipsN.V., General Electric Company, OMRON Corporation, B. Braun Melsungen AG, LIDCOLtd., Medtronic, Inc., Drägerwerk AG & Co. KGaA, Nihon Kohden Corporation,Schwarzer Cardiotek GmbH, Osypka Medical GmbH, and Tensys Medical Inc.
Global Hemodynamic Monitoring SystemMarket: Key Developments
In December 2019, Masimoannounced that a study published in the Journal of Clinical Monitoring andComputing assessed the accuracy of three hemoglobin (Hb) monitoring methods,including noninvasive, continuous Masimo SpHb.
In November 2019, Saranas, Inc.announced completion of the first U.S. commercial case using the Early BirdBleed Monitoring System for real-time detection and monitoring of endovascularbleed complications.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/1070
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
